Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and

Rafet Gunay1, Yavuz Sensoz, Ilyas Kayacioglu

  • 1Department of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey. rafetgunay@hotmail.com

Insights

Aortic valve pathology type does not impact long-term survival in patients undergoing aortic valve replacement (AVR) and coronary artery bypass grafting (CABG). This study found no significant differences in survival rates based on aortic stenosis, regurgitation, or mixed-type valve disease.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Valvular Heart Disease

Background:

  • Concomitant aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) is a common procedure for patients with combined aortic valve disease and coronary artery disease.
  • Understanding the impact of different aortic valve pathologies on surgical outcomes is crucial for patient management.

Purpose of the Study:

  • To evaluate the effect of aortic valve pathology type (aortic stenosis, aortic regurgitation, mixed-type) on long-term survival after combined AVR-CABG surgery.
  • To identify risk factors associated with early and late mortality in this patient population.

Main Methods:

  • Retrospective review of 150 patients who underwent AVR-CABG between 1997 and 2006.
  • Patients were categorized into three groups based on aortic valve pathology: aortic stenosis (AS), aortic regurgitation (AR), and mixed-type.
  • Analysis of operative mortality, 5-year, and 10-year survival rates, along with early and late mortality risk factors.

Main Results:

  • No significant differences in operative mortality or 5/10-year survival rates were observed among the AS, AR, and mixed-type groups.
  • Early mortality was associated with longer cross-clamp/cardiopulmonary bypass times, blood transfusions, COPD, IABP use, inotropic drugs, and pacemaker use.
  • Late mortality was linked to ICU stay, IABP use, stroke, and dialysis.

Conclusions:

  • Aortic valve pathology type does not adversely affect long-term survival in patients undergoing concomitant AVR-CABG.
  • Identifying and managing early and late mortality risk factors is essential for improving outcomes in patients undergoing combined AVR-CABG.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...